As a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, tirzepatide enhances insulin secretion, suppresses glucagon release, and slows gastric emptying
Impact of C-peptide preservation on metabolic and clinical outcomes in the diabetes control and complications trial
Common side effects can include mild nausea, digestive changes, or decreased appetite, which typically improve over time
To combat diabetes and obesity, providers and patients are turning to prescription medications such as glucagon-like peptide-1 (GLP-1) receptor agonists
Stephanie Soechtig/2018/88 min/Environmental & Social Justice Saturday, March 2, 2 p.m
Some focus almost entirely on getting you medication, while others combine prescriptions with medical oversight, coaching, and habit-building tools